Literature DB >> 149362

Stimulating capacity of human lymphoid cell subpopulations in mixed lymphocyte cultures.

D Albrechtsen, M Lied.   

Abstract

The content and yield or B cells, T cells and monocytes were investigated in cell fractions separated from human peripheral blood by various techniques. These cell fractions, which were highly enriched for either B cells, T cells or monocytes, were tested for their capacity to stimulate allogenic peripheral blood mononuclear cells in mixed lymphocyte cultures (MLC). B cells were found to be strongly stimulatory. Monocytes stimulated strongly at low stimulator/responder cell ratios, while less stimulation was observed using larger amounts of cells. T cells were demonstrated to stimulate weakly, if at all.

Entities:  

Mesh:

Year:  1978        PMID: 149362     DOI: 10.1111/j.1365-3083.1978.tb00474.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.

Authors:  J P Halper; S M Fu; A B Gottlieb; R J Winchester; H G Kunkel
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

2.  Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions.

Authors:  M Nieda; T Juji; S Imao
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  Variation in accessory cell requirements in human mixed lymphocyte response to leukaemic cell lines.

Authors:  D O'Keefe; L Ashman
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

4.  Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).

Authors:  H Orjasaeter; G Jordfald; I Svendsen
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.